PEPTIDES
Clinical trials for PEPTIDES explained in plain language.
Never miss a new study
Get alerted when new PEPTIDES trials appear
Sign up with your email to follow new studies for PEPTIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Migraine mystery: does amylin spark attacks?
Knowledge-focused Not yet recruitingThis study looks at whether a drug called pramlintide, which mimics a natural body chemical (amylin), can cause migraine attacks in people who get migraines without aura. About 21 adults with a history of migraine without aura will receive either pramlintide or a placebo, and res…
Matched conditions: PEPTIDES
Phase: NA • Sponsor: Danish Headache Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:08 UTC
-
Scientists investigate whether a diabetes drug can spark headaches in brain injury survivors
Knowledge-focused Not yet recruitingThis study looks at whether pramlintide, a substance similar to a natural hormone, can cause migraine-like headaches in people who have had persistent headaches for at least a year after a mild traumatic brain injury. About 21 adults aged 18 to 65 will receive either pramlintide …
Matched conditions: PEPTIDES
Phase: NA • Sponsor: Danish Headache Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC
-
Migraine mystery: new study probes Adrenomedullin's role
Knowledge-focused Not yet recruitingThis study looks at whether a natural brain chemical called adrenomedullin can cause migraine attacks in people who already get migraines. Researchers will give the chemical to 26 adults with migraine without aura, after they have taken a preventive migraine drug (erenumab). The …
Matched conditions: PEPTIDES
Phase: NA • Sponsor: Danish Headache Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC